HPV analyzers - CPT - FY24

Ended Purchase Order Awarded Last action

Contract number
W81K0023P0198
Awardee
Awarding agency
Obligated
$1,001,717

Award facts

Contract value 28% obligated
  • $1,001,716.64 Current, with exercised options
  • $3,524,806.52 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 · HPV analyzers - CPT - FY25 DE-obligation of funds -$280,343
Funding Only Action P00004 · HPV analyzers - CPT - FY25 funding modification. $841,030
Funding Only Action P00003 · HPV analyzers - CPT - FY25 -$400,000
Exercise an Option P00002 · HPV analyzers - CPT - exercise FY25 option year $0
Funding Only Action P00001 · HPV analyzers - CPT - FY24 - funding modification $841,030
Original award $0

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded a $3.52 million firm fixed-price purchase order to Roche Diagnostics Corporation on October 1, 2023, for human papillomavirus (HPV) analyzers and associated services to support the Brooke Army Medical Center Department of Pathology and Area Laboratory Services Microbiology Laboratory at Fort Sam Houston, Texas. The contract, which extends through September 30, 2028, fulfills a pre-solicitation requirement for FDA-approved HPV testing instrumentation and reagents capable of automated sample handling and integration with the MHS Genesis electronic health record system. The procurement was conducted without set-aside designation, reflecting open competition among qualified vendors. Roche Diagnostics Corporation, a foreign-owned manufacturer headquartered in Indianapolis and specializing in in vitro diagnostic solutions, is well-positioned to deliver these capabilities through its extensive portfolio of molecular diagnostic analyzers and reagents.

This award represents one of multiple Defense Health Agency contracts held by Roche Diagnostics, which maintains several indefinite delivery contracts and blanket purchase agreements across the Department of Veterans Affairs and military medical facilities. The company's existing $6.75 million indefinite delivery contract with DHA for a fully automated sample preparation and consultation system at Brooke Army Medical Center, along with its $5.995 million contract for reagents and consumables supporting a government-owned Roche Diagnostic Total Laboratory Automation system, demonstrates an established operational presence at the performance location. The HPV analyzer award provides Fort Sam Houston's microbiology laboratory with automated processing capabilities designed to handle approximately 94 samples per 30-minute cycle, supporting pathology operations at the main hospital and surrounding military clinics.

Quick answers

Who was awarded contract W81K0023P0198?

W81K0023P0198 was awarded to Roche Diagnostics Corporation by Medical Command (Department of the Army) on October 1, 2023.

How much is contract W81K0023P0198 worth?

The government has obligated $1,001,717 on W81K0023P0198. Its potential value, with all options, is $3,524,807.

Which agency awarded contract W81K0023P0198?

Medical Command (Department of the Army) awarded W81K0023P0198, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0023P0198 competed?

The extent of competition for W81K0023P0198 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login